Trends in Cardiovascular Medicine
Volume 19, Issue 1 , Pages 1-5, January 2009

P2X1 Receptor Inhibition and Soluble CD39 Administration as Novel Approaches to Widen the Cardiovascular Therapeutic Window☆☆

  • C.Y.E. Fung

      Affiliations

    • Department of Cell Physiology and Pharmacology, University of Leicester, LE1 9HN Leicester, United Kingdom
  • ,
  • Aaron J. Marcus

      Affiliations

    • Hematology-Oncology, VA NY Harbor Healthcare System/Weill Cornell Medical College, New York, USA
  • ,
  • M. Johan Broekman

      Affiliations

    • Hematology-Oncology, VA NY Harbor Healthcare System/Weill Cornell Medical College, New York, USA
  • ,
  • Martyn P. Mahaut-Smith

      Affiliations

    • Department of Cell Physiology and Pharmacology, University of Leicester, LE1 9HN Leicester, United Kingdom
    • Corresponding Author InformationAddress correspondence to: Prof Martyn P. Mahaut-Smith, Department of Cell Physiology and Pharmacology, University of Leicester, Maurice Shock Medical Sciences Building, University Road, PO Box 138, LE1 9HN Leicester, United Kingdom. Tel.: (+44) 1162297135; fax: (+44) 1162525045.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 All authors contributed equally to this manuscript.

☆☆ C.Y.E. Fung and M.P. Mahaut-Smith were supported by the British Heart Foundation (PG/05/014). A.J. Marcus and M.J. Broekman were supported by NIH 5R37HL047073 and 5P01HL046403 and a MERIT REVIEW grant from the Department of Veterans Affairs.

PII: S1050-1738(09)00027-9

doi:10.1016/j.tcm.2009.01.005

Trends in Cardiovascular Medicine
Volume 19, Issue 1 , Pages 1-5, January 2009